PAEDIATRICS Metronomics - fulfilling unmet needs beyond level A evidence

被引:5
作者
Andre, Nicolas [1 ,2 ,3 ]
Banavaliand, Shripad [3 ,4 ]
Pasquier, Eddy [1 ,3 ]
机构
[1] Aix Marseille Univ, Fac Pharm, Ctr Rech Oncol Biol & Oncopharmacol, Inserm,UMR S 911, 27 Blvd Jean Moulin, F-13005 Marseille, France
[2] AP HM, Serv Hematol & Oncol Pediat, F-13005 Marseille, France
[3] Metron Global Hlth Initiat, F-13005 Marseille, France
[4] Tata Mem Hosp, Dept Med Oncol, Dr E Borges Rd, Bombay 400012, Maharashtra, India
关键词
MIDDLE-INCOME COUNTRIES; CHILDREN; CANCER; CHEMOTHERAPY; THERAPY;
D O I
10.1038/nrclinonc.2016.102
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To improve the survival rates globally for paediatric patients with cancer, looking beyond level A evidence to treat children in low and middle-income countries is imperative. Herein, we discuss why metronomic chemotherapy, which is less toxic and more affordable, offers a pragmatic approach to provide new standards for patients with relapsed disease who have no alternatives.
引用
收藏
页码:469 / +
页数:2
相关论文
共 12 条
[1]   Maintenance chemotherapy in children with ALL exerts metronomic-like thrombospondin-1 associated anti-endothelial effect [J].
Andre, Nicolas ;
Cointe, Sylvie ;
Barlogis, Vincent ;
Arnaud, Laurent ;
Lacroix, Romaric ;
Pasquier, Eddy ;
Dignat-George, Francoise ;
Michel, Gerard ;
Sabatier, Florence .
ONCOTARGET, 2015, 6 (26) :23008-23014
[2]   Metronomics: towards personalized chemotherapy? [J].
Andre, Nicolas ;
Carre, Manon ;
Pasquier, Eddy .
NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (07) :413-431
[3]   Has the time come for metronomics in low-income and middle-income countries? [J].
Andre, Nicolas ;
Banavali, Shripad ;
Snihur, Yuliya ;
Pasquier, Eddy .
LANCET ONCOLOGY, 2013, 14 (06) :E239-E248
[4]   Improving Care for Children With Cancer in Low- and Middle-Income Countries-A SIOP PODC Initiative [J].
Arora, Ramandeep Singh ;
Challinor, Julia M. ;
Howard, Scott C. ;
Israels, Trijn .
PEDIATRIC BLOOD & CANCER, 2016, 63 (03) :387-391
[5]   Single-Drug Vinblastine As Salvage Treatment for Refractory or Relapsed Anaplastic Large-Cell Lymphoma: A Report From the French Society of Pediatric Oncology [J].
Brugieres, Laurence ;
Pacquement, Helene ;
Le Deley, Marie-Cecile ;
Leverger, Guy ;
Lutz, Patrick ;
Paillard, Catherine ;
Baruchel, Andre ;
Frappaz, Didier ;
Nelken, Brigitte ;
Lamant, Laurence ;
Patte, Catherine .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (30) :5056-5061
[6]   Children Treated With Metronomic Chemotherapy in a Low-income Country: METRO-MALI-01 [J].
Fousseyni, Traore ;
Diawara, Maimouna ;
Pasquier, Eddy ;
Andre, Nicolas .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (01) :31-34
[7]   Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors [J].
Kahalley, Lisa S. ;
Ris, M. Douglas ;
Grosshans, David R. ;
Okcu, M. Fatih ;
Paulino, Arnold C. ;
Chintagumpala, Murali ;
Moore, Bartlett D. ;
Guffey, Danielle ;
Minard, Charles G. ;
Stancel, Heather H. ;
Mahajan, Anita .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) :1043-+
[8]  
Lakshmaiah K. C., 2013, J CANCER RES THER, V9, P649
[9]   Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial [J].
Le Tourneau, Christophe ;
Delord, Jean-Pierre ;
Goncalves, Anthony ;
Gavoille, Celine ;
Dubot, Coraline ;
Isambert, Nicolas ;
Campone, Mario ;
Tredan, Olivier ;
Massiani, Marie-Ange ;
Mauborgne, Cecile ;
Armanet, Sebastien ;
Servant, Nicolas ;
Bieche, Ivan ;
Bernard, Virginie ;
Gentien, David ;
Jezequel, Pascal ;
Attignon, Valery ;
Boyault, Sandrine ;
Vincent-Salomon, Anne ;
Servois, Vincent ;
Sablin, Marie-Paule ;
Kamal, Maud ;
Paoletti, Xavier .
LANCET ONCOLOGY, 2015, 16 (13) :1324-1334
[10]   Paediatric cancer in low-income and middle-income countries [J].
Magrath, Ian ;
Steliarova-Foucher, Eva ;
Epelman, Sidnei ;
Ribeiro, Raul C. ;
Harif, Mhamed ;
Li, Chi-Kong ;
Kebudi, Rejin ;
Macfarlane, Scott D. ;
Howard, Scott C. .
LANCET ONCOLOGY, 2013, 14 (03) :E104-E116